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Abstract
Several structural brain abnormalities have been associated with aggression in patients with
schizophrenia. However, little is known about shared and distinct abnormalities underlying
aggression in these subjects and non-psychotic violent individuals. We applied a region-of-
interest volumetric analysis of the amygdala, hippocampus, and thalamus bilaterally, as well
as whole brain and ventricular volumes to investigate violent (n = 37) and non-violent chronic
patients (n = 26) with schizophrenia, non-psychotic violent (n = 24) as well as healthy control
subjects (n = 24). Shared and distinct volumetric abnormalities were probed by analysis of
variance with the factors violence (non-violent versus violent) and diagnosis (non-psychotic
versus psychotic), adjusted for substance abuse, age, academic achievement and negative
psychotic symptoms. Patients showed elevated vCSF volume, smaller left hippocampus
and smaller left thalamus volumes. This was particularly the case for non-violent individuals
diagnosed with schizophrenia. Furthermore, patients had reduction in right thalamus size.
With regard to left amygdala, we found an interaction between violence and diagnosis. More
specifically, we report a double dissociation with smaller amygdala size linked to violence in
non-psychotic individuals, while for psychotic patients smaller size was linked to non-vio-
lence. Importantly, the double dissociation appeared to be mostly driven by substance
abuse. Overall, we found widespread morphometric abnormalities in subcortical regions in
schizophrenia. No evidence for shared volumetric abnormalities in individuals with a history
of violence was found. Finally, left amygdala abnormalities in non-psychotic violent individu-
als were largely accounted for by substance abuse. This might be an indication that the
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association between amygdala reduction and violence is mediated by substance abuse.
Our results indicate the importance of structural abnormalities in aggressive individuals.
Introduction
There is a growing interest to further our understanding of violence and aggression in patients
with severe mental illness. Violent behavior is a public health concern, and there is evidence of
increased rates of violence in patients with schizophrenia [1–3]. Although violence is deter-
mined by multiple factors, emerging evidence suggests that emotional regulation, the ability to
modulate one’s state or behavior in a given situation plays an important role in aggressive
behavior [4–6]. Here, we investigate brain structures associated with emotional regulation
comparing schizophrenia patients with (VS) and without a history of violence (NVS) as well as
non-psychotic violent individuals (NPV) to delineate neuroanatomical abnormalities linked to
psychosis and aggression.
Converging evidence from focal brain lesion studies [7], functional imaging [5, 8] and neu-
rotransmitter functioning [9–11] in aggressive individuals implicates the amygdala in the etiol-
ogy of violence, with the amygdala considered a key structure in several neurobiological
models of violence [12–14]. For example, the Siever model [14] proposes that violence and
aggression occur when amygdala-mediated affective responses are not inhibited, and this lack
of inhibition prevents the impulsive drive from being constrained. Deficits in inhibition, along
with perceived urgency and difficulties in self-regulation associated with prefrontal cortex dys-
function increase the risk of violence [15–18].
Studies of patients with schizophrenia have shown aberrant brain structures and functions
in limbic and frontal regions. The hippocampus and whole brain volume are consistently
found to be reduced in volume in patients with schizophrenia [19–23], particularly so in
patients with a history of violence [24–27]. Applying resting-state functional magnetic reso-
nance imaging (fMRI), Hoptman and colleagues [28] showed reduced functional connectivity
(FC) between the amygdala and ventral prefrontal regions in patients with schizophrenia, with
lower connectivity associated with higher levels of self-rated aggression. Recently, we used
event-related brain potentials to show a delay of approximate 150 millisecond in sensory-per-
ceptual responses to emotionally salient stimuli in schizophrenia patients with a history of vio-
lence relative to their non-violent peers [29]. Given this deficit is related to the processing of
negatively valenced stimuli, aberrant amygdala functioning must be considered. Hence, there
is consistent evidence of aberrant brain functions linked to emotional regulation and its role in
aggression.
Interestingly, structural imaging studies of the amygdala in violent patients with schizo-
phrenia have yielded mixed results. One early study found temporal lobe volume reduction in
violent patients [30] in contrast to more recent work [24–26, 31]. Barkataki and colleagues
[24] found that non-violent patients showed amygdala reductions relative to healthy controls
and violent patients, but differences between patient groups were lost after controlling for pos-
itive symptoms. Similar results were reported in two more investigations with amygdala reduc-
tions seen in non-violent patients [25, 26]. One of the studies also reported a weak trend
towards a reduction in violent patients compared to healthy controls [25]. All the above studies
unfortunately are characterized by small sample sizes (ranging from 10 to 13 for violent
patients), which might contribute to these inconsistent findings. Considering the rather robust
functional evidence implicating amygdala in aggression, further structural studies with larger
sample sizes are clearly warranted.
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The relationship between amygdala reduction and violence appears to be somewhat more
consistent in non-clinical samples, which raises the important question about differential neu-
ronal contributions to violence. Using the symptom check list to confirm the absence of psy-
chiatric disorders (SCL-90-R)[32], Matthies and colleagues classified individuals as aggressive
based on their Lifetime History of Aggression score (LHA > 5)[33]. They reported smaller
bilateral amygdala volumes in aggressive individuals. Lending support to the specificity of
their findings, amygdala size correlated with LHA scores, but not with other clinical measures
looking at general psychopathology, anxiety, and depression. Similar results were reported by
Bobes Leon et al [34] applying the Reactive and Proactive Aggression Questionnaire [35] to
measure aggressiveness in adult men. Amygdala size was found to be smaller in the violent
group and negatively correlated with trait scores of reactive aggression. Notably, total score on
the psychopathy checklist for the violent group at 10.6 was far below the commonly used cut-
off score of 25 for psychopathy [36]. In a recent longitudinal study, amygdala volumes mea-
sured at 26 years of age were associated with psychopathic features and levels of aggression
measured in youth. Yet, group volumetric differences between adult individuals with a history
of chronic, transient, and no serious violence were not significant [37].
Investigations on the issue of violence in schizophrenia have produced promising results,
but studies with small sample size and inclusion of comorbid disorders [24–26, 31] make inter-
pretation of volumetric changes less clear. Including a non-psychotic, violent sample without a
history of any major Axis I disorder, or any current substance abuse problems will help distin-
guish neuroanatomical abnormalities associated with aggression and psychosis.
Methods
Participants
Region of interest (ROI) analysis for non-violent patients with schizophrenia (NVS; n = 26),
violent patients with schizophrenia (VS; n = 37), non-psychotic, violent participants (NPV;
n = 24), and healthy control participants (HC; n = 24) were carried out (for list of abbreviations
see Table 1). All participants, as reported in our previous studies using the same participants
[29, 38], had no significant co-morbid medical, psychiatric, or neurological illnesses. Partici-
pants with any history of drug or alcohol dependence were excluded, along with any recent
Table 1. Abbreviations.
Healthy Controls HC
Nonviolent patients with schizophrenia NVS
Violent patients with schizophrenia VS
Non-psychotic violent participants NPV
Whole Brain Volume WBV
Ventricular Cerebrospinal Fluid vCSF
Positive and Negative Syndrome Scale PANSS
PANSS General Score panGS
PANSS Total Score panTS
PANSS Positive Score panPS
PANSS Negative Score panNS
Substance Abuse Disorder SUD
Wide Range Achievement Test WRAT-4
Life History of Aggression LHA
Barratt Impulsiveness Scale-11 BIS-11
doi:10.1371/journal.pone.0168100.t001
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drug or alcohol abuse occurring 6 months or less to their participation in the study. The struc-
tured clinical interview for DSM-IV-TR disorders (SCID-IV DSM-IV-TR)[39, 40] was used
for diagnostic purposes for all four groups, including the confirmation that our HC and NPV
participants did not meet criteria for any Axis 1 psychiatric disorders. The patient population
was recruited from the Rockland Psychiatric Center (Rockland, NY). In particular, patients
were recruited from the Nathan S. Kline Institute (NKI) inpatient facilities, as well as outpa-
tient centers in New York State. Non-patient participants were recruited from the volunteer
recruitment pool at NKI. Informed written consent was obtained from all participants. NKI
IRB approved consent forms were used for this process. The experimental protocol was
approved by the institutional review board at NKI and is compliant with the tenets set forth in
the Declaration of Helsinki.
Clinical Assessment
The Life History of Aggression (LHA) [41] form was completed for all participants to help
determine grouping (e.g. violent or non-violent). Participants report during interview, avail-
able official criminal records ("Record of Arrest and Prosecution"), staff interviews, and chart
review was used to complete the LHA. The LHA scale has strong inter-rater and test-retest reli-
ability, good internal consistency, and is considered a valid measure of overt aggression [41].
Scores 20 on the LHA, plus a confirmed episode of physical assault in the past year, in con-
junction with a score 3 on the "Physical Aggression Against People" (PA-people) subscale,
met criteria for inclusion in the two violent groups (e.g. VS and NPV). To be included in the
non-violent group, there could be no evidence of a physical assault within the past year, or any
lifetime episodes of severe physical aggression, accompanied with a score 15 on the LHA,
and 2 on the PA-people. This study used the same inclusion and exclusion criteria found in
our previous studies [29, 38].
The Buss-Perry Aggression Questionnaire [42], is a 29-item measure, comprised of four
dimensions (physical aggression, verbal aggression, hostility, and anger). There is moderate to
high internal consistency, with stable test-retest scores over 7 months, and it has good conver-
gent validity, although there is a moderate negative relationship with social desirability [43].
The Barratt Impulsiveness Scale (BIS-11) [44] is a widely used measure of impulsive person-
ality traits that is multi-dimensional with strong internal consistency, test-retest reliability, and
convergent validity [45].
The Wide Range Achievement Test–Fourth Edition, Reading Subtest (WRAT-4) was used
to estimate academic achievement skills and IQ [46]. Age-adjusted T-scores were used for all
analyses.
The Positive and Negative Syndrome Scale for Schizophrenics (PANSS) [47] was used to
help characterize the schizophrenia patient population. The PANSS has been found to have
good psychometric properties with no inter-correlation between the negative and positive
scales suggesting separate dimensions of psychopathology [47, 48]. Only patients with schizo-
phrenia were administered the PANSS.
Neuroimaging Acquisition and Data Processing
T1-weighted magnetic resonance (MR) images were acquired with a 1.5T Siemens Vision
scanner (Erlangen, Germany) at the NKI Center for Advanced Brain Imaging (Orangeburg,
NY), which was equipped with a 30.5-cm i.d. three-axis local gradient coil and an end-capped
quadrature birdcage radio-frequency coil. All participants were scanned with the following
high-resolution T1-weighted magnetization prepared rapidly acquired gradient echo
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(MPRAGE) parameters: TR = 11.6 ms, TE = 4.9 ms, flip angle 8˚, FOV = 300 mm, matrix =
256x256, slice thickness = 1.2 mm isotropic voxels, and 172 sagittal slices.
Individual volumes were concatenated using AFNI (to3d function; NIMH Bethesda, MD,
USA, http://afni.nimh.nih.gov/afni/) to create a single 3D MRI image per participant, prior to
using FSL (FMRIB—Oxford; http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) for segmentation. An auto-
matic approach to the segmentation of subcortical structures, called FIRST was used [49, 50]
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FIRST). A benefit of using an automated approach is that
manual segmentation is time consuming, since it requires the accurate demarcation of struc-
tures and associated anatomical landmarks. Automated packages, such as FIRST, can reliably
segment volumes in a fraction of the time, and does not require expert neuroanatomists to
manually draw masks. FIRST has the capabilities to automatically delineate and segment sub-
cortical structures using a Bayesian based model that creates surface meshes on sub-cortical
structures. A large training data-set of 336 T1-weighted MR images from the Center for Mor-
phometric Analysis (CMA; Massachusetts General Hospital, Boston, USA) was used to manu-
ally segment 15 structures [50]. Among those structures were the left and right amygdala,
hippocampus, and thalamus. As part of the subcortical segmentation to MNI space, FIRST
applies a 12 degrees of freedom affine registration of the T1 image to the FSL FIRST training
library, followed by a second 12 degree of freedom registration using an MNI subcortical mask
to ensure voxels outside of the regions of interest are not incorrectly included in the volumes.
In addition to utilizing FIRST, the cross-sectional version of SIENA ("Structural Image
Evaluation using Normalization of Atrophy") called SIENAX was used to estimate whole
brain tissue volume from a single T1-weighted image. The process segments brain tissue
from non-brain tissue [51, 52] before the brain is affine-registered to MNI152 space [53,
54]. Both, the normalized (e.g. MNI 152) and unnormalized (native) values are provided
as outputs. This approach also extracts the grey and white matter, peripheral grey matter,
and ventricular cerebrospinal fluid (vCSF) volumes using a partial volume estimation
approach [55]. Since FIRST uses linear and non-linear transformations to normalize brain
tissue prior to segmentation, we used the normalized values for WBV and vCSF for our
analyses. SIENAX has been validated to differentiate clinical groups from a single time-
point, with a 0.5–1% brain volume accuracy for SIENAX measures, compared with longi-
tudinal SIENA brain volume change error of 0.15% [56]. It has been found that the estima-
tion of the normalized brain volume accuracy of SIENAX is closely correlated with the
SIENA measure [57]. vCSF volume was used as a proxy to measure ventricular size in our
current study.
Statistical analyses were carried out using SPSS (IBM SPSS Statistics Version 20). Statis-
tical outliers were excluded from analysis if their ROI volume was 2.5 or more standard
deviations from the mean. Prior to excluding any outliers, T1-weighted MRI and the seg-
mentation output quality were first verified. If the segmentation did not occur correctly, it
was re-processed to ensure that an error did not occur during the segmentation. In this
study, there were no segmentation errors. Due to motion artifact on T1-weighted MR
images and significant statistical outliers we excluded six participants in total from the
analysis (2 HCs, 1 VS, 1 NVS, and 2 NPV). To determine shared and distinct volumetric
abnormalities, we applied analysis of variance (ANOVA) to test main and interactive
effects between factors violence (non-violent versus violent) and diagnosis (non-psychotic
versus psychotic). ANOVA was adjusted for substance abuse, age, academic achievement
and negative psychotic symptoms. Bonferroni was used to correct for multiple post hoc
pairwise comparisons.
Neuroanatomy of Violence in Schizophrenia
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Results
Demographic and Clinical Variables
Demographic statistics are reported in Table 2. No difference in gender was observed between
the groups, with the sample being largely comprised of men. No difference was also seen in
medication dose, as measured using chlorpromazine equivalency values. Chlorpromazine
equivalents were calculated following the guidelines published in [58]. The percentage of atypi-
cal and typical antipsychotic medication was 70% and 30%, respectively. There was a signifi-
cant difference in age among groups (F3,107 = 2.94, p = .036), with NVS, older compared to
HC, VS, and NPV. Groups also differed in years of education (F3, 109 = 10.7, p< .001), with HC
having spent more years at school than VS, NPV, and NVS. Age at first hospitalization did not
differ between the VS and NVS (t57 = 0.799, p = .428), although the duration of illness was lon-
ger for the NVS group than the VS group (t56 = 2.30, p = .025). Differences were also observed
for WRAT-4 performances across groups (F3,106 = 3.82, p = .012), with HC participants obtain-
ing higher achievement scores than the other three groups. Age and WRAT-4 were used as
covariates in all subsequent ROI analysis, along with substance abuse disorder.
Additionally, we saw group differences on the Buss-Perry Questionnaire Total Score
(BPAQ; F3,107 = 10.05, p< .001). BPAQ total scores were higher in VS and NPV relative to HC
and NVS. For the physical aggression subscale of the BPAQ, NPV participants scored higher
Table 2. Demographic and clinical data.
HC NVS VS NPV f/chi/t value P-value
N 24 26 37 24 - -
Gender: male/female 19/5 20/6 31/7 23/1 10.03 .124
Age (s.e.m.) 30.04 (2.1) 43.08 (1.9) 35.3 (1.6) 38.8 (2.1) 2.94 .036*
Age of first hospitalization – 23.94 (6.62) 22.09 (9.37) – .799 .428
Illness Duration – 19.79 (1.89) 13.79 (1.73) – 2.30 .025*
Education in years 14.6 (0.4) 13.2 (0.4) 11.7 (0.3) 12.4(0.4) 10.70 .000 ***
Medication dose (CPZ equivalents) – 1343.7 (687.4) 1230.6 (637.8) – 0.65 .52
Substance Abuse 2/24 5/26 18/37 14/24 20.011 .000***
WRAT-4 50.3 (1.8) 42.1 (2.1) 45.1(1.2) 43.2 (2.1) 3.82 .012*
LHA Total 13.83 (1.31) 10.28 (.97) 25.61 (.98) 33.13 (1.18) 64.23 .000***
Barratt Impulsivity 55.13 (1.79) 61.27 (2.49) 62.31 (1.85) 65.92 (2.14) 4.12 .008*
Buss-Perry Total 56.46 (2.71) 63.89 (4.23) 77.12 (3.00) 85.17 (5.58) 10.05 .000***
Buss-Perry Physical 15.38 (1.02) 15.64 (1.39) 22.25 (1.19) 26.52 (1.90) 14.02 .000***
Buss-Perry Verbal 13.13 (.86) 11.88 (.94) 14.12 (.83) 16.33 (1.03) 3.89 .011*
Buss-Perry Anger 11.71 (.60) 14.35 (1.07) 18.21 (1.08) 21.54 (1.88) 11.35 .000***
Buss-Perry Hostility 16.13 (1.14) 20.96 (1.66) 22.03 (.94) 21.33 (1.56) 3.99 .01*
panTT – 78.5 (14.2) 79.1 (12.9) – -0.17 .866
panGS - 38.7 (1.5) 40.5 (1.2) - .89 .349
panPS – 18.7 (5.4) 20.68 (6.4) – -1.28 .21
panNG – 21.1 (5.3) 17.89 (5.4) – 2.27 .027 *
ANOVA or t-test for continuous and chi-square test for categorical variables.
* P 0.05
** P 0.001
*** P .0001.
S.E.M. = standard error of mean; S.E.M. are the values in parenthesis; CPZ = chlorpromazine; panTT = PANSS Total Score; panGS = PANSS General
Score; panPS = PANSS Positive Score; panNG = PANSS Negative Score; LHA = Life History of Aggression
doi:10.1371/journal.pone.0168100.t002
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than VS, and both violent groups reported more physical aggression than NVS and HC. For
the verbal aggression subscale of the BPAQ, NPV participants scored higher than HC and
NVS. Differences between VS and the other three groups did not reach significance. Further-
more, VS and NPV participants scored higher on anger than NVS and HC. Finally, on the hos-
tility subscale, VS, NPV, and NVS participants scored higher than HC. There were no
differences between NPV, VS, and NVS groups.
Life history of aggression scores also differed between the four groups (F3, 108 = 67.49, p<
.001). The NPV group was more violent than the VS group, with both of these groups scoring
higher on the LHA than both the NVS and HC groups. HC participants had elevated LHA
scores relative to the NVS group.
There was a main effect of group (F3, 108 = 3.28, p = .024) for Barrett’s Impulsivity Index.
Follow-up pair-wise comparisons revealed increased impulsivity in VS and NPV groups rela-
tive to HC participants. The NVS group did not differ from the HC group, or the two violent
groups.
NVS and VS did not differ in PANSS total scores, general scores, or positive symptoms.
However, NVS scored significantly higher on negative symptoms (t59 = 2.27, p = 0.02). For this
reason, a secondary analysis looking at the effect of negative symptoms as a contributing factor
to ROI volume was conducted.
Region of Interest Volumetric Analysis
Fig 1 illustrates brain regions investigated in our study mapped onto a participant’s brain.
Fig 1. T1-weighted MRI ROI FIRST masks.
doi:10.1371/journal.pone.0168100.g001
Neuroanatomy of Violence in Schizophrenia
PLOS ONE | DOI:10.1371/journal.pone.0168100 December 28, 2016 7 / 17
Table 3 lists mean volumes of investigated brain regions for each of the four groups.
Whole Brain Volume. The ANOVA for WBV revealed no significant main and interac-
tive effects.
Fig 2 illustrates the effects of violence and diagnosis on brain region volumes.
Left and Right Amygdala. The ANOVA for left amygdala indicated a trend towards a
main effect for diagnosis (F1,109 = 3.89, p = .051). For the right amygdala, a significant interac-
tion between diagnosis and violence was found (F1,109 = 5.3, p = .023). However, only a trend
towards an interaction was observed after including substance abuse as a covariate (F1,109 =
3.679, p = .05). The interaction appeared to be driven by a double dissociation between factors,
with decreased volume in NPV relative to HC and increased volume in VS relative to NVS.
Bonferroni corrected post hoc pairwise comparison using independent samples t-test revealed
no differences between groups.
Table 4 lists results obtained by analysis of variance.
Left and Right Hippocampus. For the left hippocampus volume, there was a main effect
of diagnosis (F1,109 = 4.08, p = 0.04) with reduction seen for patients with schizophrenia. There
was also an interaction between diagnosis and violence (F1,109 = 5.46, p = 0.02). Corrected post
hoc pairwise comparisons revealed a group difference between NVS and HC (p = .026) for left
hippocampal volume. No effects were found for the right hippocampus.
Left and Right Thalamus. For both left and right thalamus, ANOVA revealed a main
effect for diagnosis (LT: F1,109 = 11.12, p = 0.001; RT: F1,109 = 7.69, p = 0.007) with reduction
seen in patients with schizophrenia. Furthermore, a significant interaction between diagnosis
and violence was observed for the left thalamus (F1,109 = 8.35, p = 0.005). Post hoc pairwise
comparisons revealed a group difference between NVS and HC (p< .001).
Ventricular Cerebrospinal Fluid. Due to issues of skewness, vCSF was transformed
using a natural log to approximate a Gaussian distribution. Analysis indicated a main effect for
diagnosis (F1,109 = 27.88, p = 0.001) with increased vCSF volume for patients with schizophre-
nia. Furthermore, there was a significant interaction between diagnosis and violence (F1,109 =
5.82, p = 0.01). Post hoc pairwise comparisons revealed increased volume in NVS (p< .001)
and VS (p = .008) relative to HC, as well as increased volume in NVS relative to NPV (p =
.002).
The Role of Negative Symptoms and Medication. Here the analysis was limited to
patients with a diagnosis of schizophrenia to investigate the potential role of several factors,
such as medication, negative symptoms, and illness duration on gray matter volume loss. As
indicated in Table 2, there was no group difference for CPZ equivalent. Further, CPZ equiva-
lent did not correlate with WBV (p = .79), vCSF (p = .26), left amygdala (p = .43), left
Table 3. Adjusted means and standard deviations of the means for ROI.
ROI HC NVS VS NPV
WBV 1610692.14 (118229.65) 1548997.75 (91300.21) 1581467.20 (115945.47) 1562300.89 (79828.58)
Left Amygdala 1290.66 (140.28) 1175.94 (157.60) 1178.25 (241.31) 1218.96 (217.27)
Right Amygdala 1262.81 (139.73) 1128.31 (205.87) 1207.84 (225.95) 1146.76 (304.54)
Left Hippocampus 3669.73 (352.87) 3279.93 (429.43) 3377.83 (426.97) 3328.55 (482.18)
Right Hippocampus 3803.58 (352.95) 3475.02 (321.14) 3557.10 (432.39) 3536.09 (438.81)
Left Thalamus 8345.42 (543.65) 7623.46 (408.86) 8033.83 (640.98) 8034.02 (689.26)
Right Thalamus 8127.71 (618.99) 7559.44 (652.40) 7757.86 (749.18) 7897.09 (653.89)
vCSF 10.59 (0.048) 10.63 (0.05) 10.94 (0.052) 10.75 (0.038)
Adjusted means (S.D.) reported in mm3. All ROIs were adjusted for age, substance abuse, and WRAT-4 T-scores.
doi:10.1371/journal.pone.0168100.t003
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Fig 2. ROI mean volumes for each group. Vertical error bars indicate standard error of the mean.
doi:10.1371/journal.pone.0168100.g002
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hippocampus (p = .71), left thalamus (p = .84), right amygdala (p = .93), right hippocampus
(p = .94), or right thalamus (p = .87) volumes. CPZ equivalent values were therefore not added
as a covariate. Groups did differ on age, academic achievement, substance use, as well as nega-
tive symptoms, and these variables were therefore included as covariates in our analysis. For
this subsample analysis including only patients with schizophrenia, significant differences
between patients with and without a history of violence were only found for vCSF with
increased volume seen for NVS (F1,59 = 4.63, p = 0.03).
Discussion
We set out to investigate structural characteristics in schizophrenia patients with and without
a history of violence, and compare them to non-psychotic violent and healthy control individ-
uals. Our goals were two-fold, to probe for volumetric abnormalities linked to aggression and
to determine possible differences of such abnormalities between aggressive individuals with
and without psychotic disorder. One particular interest pertained to amygdala volume as there
are somewhat conflicting results implicating this region in violence. Out of four studies [24,
26, 30, 31], only one reported an association between amygdala reduction and violence in
patients with schizophrenia. At the same time, decreased amygdala volume has been linked to
a variety of mental disorders characterized by high aggression, including conduct disorder
[59]; for a recent meta-analysis see [60] and psychopathy [61, 62].
In our study, we found several regions with structural abnormalities in patients with schizo-
phrenia. Patients showed elevated vCSF volume and smaller left hippocampus as well as left
thalamus volumes, particularly in individuals without a history of violence [63, 64]. Further-
more, patients had reduction in right thalamus size and a strong trend towards smaller left
amygdala volume was found. With regard to right amygdala, our findings indicated an interac-
tion between violence and diagnosis. The effect appeared to be driven by a double dissociation.
That is, reductions associated with violence were seen for non-psychotic individuals, while for
psychotic patient’s reductions were observed in non-violent individuals. Importantly, after
accounting for substance abuse in our analysis only a trend towards an interaction was
observed.
Overall, our findings in patients are in line with a recent large-scale study of subcortical
brain regions in 2028 individuals with schizophrenia [65]. Among other structures,
Table 4. ANOVA; f/p values are listed for main and interactive effects for each ROI.
ROI DF Diagnosis Violence Diagnosis x Violence
WBV 1 1.492 (.225) .829 (.365) 2.39 (.125)
vCSF 1 27.89 (< .0001***) .140 (.709) 5.82 (.018*)
L. Amygdala 1 3.89 (.051) .045 (.832) .554 (.459)
R. Amygdala 1 .402 (.527) .505 (.479) 3.679 (.058)
L. Hippocampus 1 4.09 (.046*) 2.01 (.160) 5.46 (.021*)
R. Hippocampus 1 3.51 (.064) .609 (.437) 3.73 (.056)
L. Thalamus 1 11.12 (.001**) .211 (.647) 8.36 (.005*)
R. Thalamus 1 7.69 (.007*) .724 (.397) 1.45 (.232)
Error 109
ANOVAs using WRAT-4 T-scores, Age, and SUD as covariates.
* P 0.05
** P 0.001
*** P .0001. Columns includes degree of freedom (DF), F-scores and p-values (italicized).
doi:10.1371/journal.pone.0168100.t004
Neuroanatomy of Violence in Schizophrenia
PLOS ONE | DOI:10.1371/journal.pone.0168100 December 28, 2016 10 / 17
abnormalities were found for hippocampus, amygdala, thalamus, and lateral ventricle volumes.
Evidence by us and others underscore widespread morphometric abnormalities in subcortical
regions possible related to aberrant integration and information transfer processes in schizo-
phrenia. Also, recent efforts to establish temporal lobe abnormalities as confirmatory biomark-
ers among youth at high-risk for development of psychosis have produced promising results
[66]. One open question concerns stronger abnormalities in non-violent patients relative to
their violent peers in our data.
With regard to our substance abuse finding it is important to note that a recent meta-analy-
sis of studies probing violence in individuals on the psychosis spectrum concluded that most
of the elevated risk was driven by patients with substance abuse comorbidity [67]. Here we
report, for the first time according to our knowledge, that substance abuse might play a medi-
ating role in the association between amygdala reduction and violence in non-psychotic vio-
lent individuals.
Considering all aggressive individuals in both the VS and NPV group, we found no evi-
dence for shared structural abnormalities underlying violence. However, there might be other
morphological markers and/or other regions of interest that might be important to consider to
determine common structural abnormalities linked to violence. Furthermore, we found no
evidence for amygdala volume reduction in violent patients with schizophrenia. Previous stud-
ies also reported no reductions in violent patients [24–26], but questions remained as to
whether these studies were sufficiently powered to detect differences. Our sample was between
two and three times larger than the ones in previous schizophrenia studies with a focus on vio-
lence [24–26], which provides a measure of confidence that amygdala size might not be part of
the structural abnormalities commonly associated with violence, at least in schizophrenia.
A limitation of the current study is the use of a 1.5T scanner, which does not provide the
same level of spatial resolution as more modern 3T scanners. Our sample is comprised of
chronic patients with schizophrenia and therefore generalizations to patients in their early
stages of illness might not be appropriate. Additionally, the self-report nature of the Buss-
Perry, which has been found to be influenced by factors of social desirability [43] could possi-
bly lead to lower scores, although the LHA scale is not based on self-report and is immune
from concerns of social desirability. Utilizing the LHA scale for grouping purposes is a
strength of the current report because of this consideration. Another strength of the study is
the use of an automated approach to segmentation (FSL’s FIRST), which has been reported to
be a reliable and valid method of subcortical segmentation [68], and is widely used by
researchers in various clinical populations [37, 69, 70]. A final, and important strength, is the
relatively large sample of clinical patients and control participants used in this study, with the
former demonstrating aberrant processing of emotionally salient images [29].
Future research should focus on other areas of grey matter that could be related to the ele-
vated rates of violence in patients with schizophrenia. In this study, due to select a priori
regions of interest, and limited regions within the FIRST library, the following regions were
not investigated. One such region is the superior temporal sulcus (STS), a region associated
with facial recognition [71, 72] which has direct projections to the amygdala [73], and which
has been found to be impaired in the schizophrenia population [74, 75]. Another region of
interest is the striatum, which includes the putamen, previously found to be enlarged in the VS
group [24]. The putamen is part of the FIRST library but was not included in this analysis
because of a priori ROI selection. OFC and PFC regions have been previously implicated in
aggression and schizophrenia and should, in concert with subcortical regions, be considered
in future research. Additionally, large scale neuroimaging and electrophysiology studies
involving genetics (e.g. MAO-A and COM-T) and their role in brain structure and function
could be helpful in delineating differences between the VS and NVS groups from NPV
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individuals. Both MAO-A and COM-T genes have been previously associated with violence
and aggression [76–81], and both have been linked with schizophrenia [82–89].
In summary, our ROI analysis of temporal and subcortical regions confirmed widespread
morphometric brain abnormalities in patients with schizophrenia. We found no evidence for
smaller amygdala size in violent patients with schizophrenia. Finally, smaller amygdala size in
violent non-psychotic individuals was mostly accounted by substance abuse problems within
this group. The latter results might provide indication that substance abuse is a potential medi-
ator in the relationship between brain abnormalities and aggression in non-psychotic individ-
uals. Overall, our results underscore the importance of volumetric abnormalities in aggression
and provide some indication for distinct brain regions in the characterization of psychotic and
non-psychotic violent individuals.
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